ArticleScientific reports2025

Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients.

Eman M F Barakat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.